178 related articles for article (PubMed ID: 10372226)
1. Mibefradil, a T-type and L-type calcium channel blocker, limits infarct size through a glibenclamide-sensitive mechanism.
Mocanu MM; Gadgil S; Yellon DM; Baxter GF
Cardiovasc Drugs Ther; 1999 Apr; 13(2):115-22. PubMed ID: 10372226
[TBL] [Abstract][Full Text] [Related]
2. Myocardial ischemia/reperfusion protection using monophosphoryl lipid A is abrogated by the ATP-sensitive potassium channel blocker, glibenclamide.
Elliott GT; Comerford ML; Smith JR; Zhao L
Cardiovasc Res; 1996 Dec; 32(6):1071-80. PubMed ID: 9015409
[TBL] [Abstract][Full Text] [Related]
3. Endothelin-1 can reduce infarct size through protein kinase C and KATP channels in the isolated rat heart.
Bugge E; Ytrehus K
Cardiovasc Res; 1996 Nov; 32(5):920-9. PubMed ID: 8944823
[TBL] [Abstract][Full Text] [Related]
4. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart.
Burley DS; Baxter GF
Basic Res Cardiol; 2007 Nov; 102(6):529-41. PubMed ID: 17896117
[TBL] [Abstract][Full Text] [Related]
5. The K(ATP) channel blocker HMR 1883 does not abolish the benefit of ischemic preconditioning on myocardial infarct mass in anesthetized rabbits.
Jung O; Englert HC; Jung W; Gögelein H; Schölkens BA; Busch AE; Linz W
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):445-51. PubMed ID: 10763861
[TBL] [Abstract][Full Text] [Related]
6. Effects of the calcium channel antagonist mibefradil on haemodynamic and morphological parameters in myocardial infarction-induced cardiac failure in rats.
Sandmann S; Spitznagel H; Chung O; Xia QG; Illner S; Jänichen G; Rossius B; Daemen MJ; Unger T
Cardiovasc Res; 1998 Aug; 39(2):339-50. PubMed ID: 9798519
[TBL] [Abstract][Full Text] [Related]
7. Remote preconditioning reduces ischemic injury in the explanted heart by a KATP channel-dependent mechanism.
Kristiansen SB; Henning O; Kharbanda RK; Nielsen-Kudsk JE; Schmidt MR; Redington AN; Nielsen TT; Bøtker HE
Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1252-6. PubMed ID: 15498829
[TBL] [Abstract][Full Text] [Related]
8. Infarct size-limiting properties of Ro 40-5967, a novel nondihydropyridine calcium channel, in anesthetized rats: comparison with verapamil.
Richard V; Tron C; Blanc T; Thuillez C
J Cardiovasc Pharmacol; 1995 Apr; 25(4):552-7. PubMed ID: 7596122
[TBL] [Abstract][Full Text] [Related]
9. Unique cardioprotective action of the new calcium antagonist mibefradil.
Schulz R; Post H; Jalowy A; Backenköhler U; Dörge H; Vahlhaus C; Heusch G
Circulation; 1999 Jan; 99(2):305-11. PubMed ID: 9892599
[TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening.
D'Souza SP; Yellon DM; Martin C; Schulz R; Heusch G; Onody A; Ferdinandy P; Baxter GF
Am J Physiol Heart Circ Physiol; 2003 May; 284(5):H1592-600. PubMed ID: 12521930
[TBL] [Abstract][Full Text] [Related]
11. Activation of mitochondrial ATP-sensitive K(+) channel for cardiac protection against ischemic injury is dependent on protein kinase C activity.
Wang Y; Hirai K; Ashraf M
Circ Res; 1999 Oct; 85(8):731-41. PubMed ID: 10521247
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of T- and L-type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats.
Nakamura Y; Ono H; Frohlich ED
Hypertension; 1999 Aug; 34(2):273-8. PubMed ID: 10454453
[TBL] [Abstract][Full Text] [Related]
13. Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide.
Mocanu MM; Maddock HL; Baxter GF; Lawrence CL; Standen NB; Yellon DM
Circulation; 2001 Jun; 103(25):3111-6. PubMed ID: 11425777
[TBL] [Abstract][Full Text] [Related]
14. Roles of tyrosine kinase and protein kinase C in infarct size limitation by repetitive ischemic preconditioning in the rat.
Tanno M; Tsuchida A; Nozawa Y; Matsumoto T; Hasegawa T; Miura T; Shimamoto K
J Cardiovasc Pharmacol; 2000 Mar; 35(3):345-52. PubMed ID: 10710117
[TBL] [Abstract][Full Text] [Related]
15. Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats.
Wang GY; Wu S; Pei JM; Yu XC; Wong TM
Am J Physiol Heart Circ Physiol; 2001 Jan; 280(1):H384-91. PubMed ID: 11123255
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the KATP-channel by glibenclamide aggravates ischemic injury, and counteracts ischemic preconditioning.
Munch-Ellingsen J; Bugge E; Ytrehus K
Basic Res Cardiol; 1996; 91(5):382-8. PubMed ID: 8922256
[TBL] [Abstract][Full Text] [Related]
17. ATP-sensitive potassium channel mediates delayed ischemic protection by heat stress in rabbit heart.
Hoag JB; Qian YZ; Nayeem MA; D'Angelo M; Kukreja RC
Am J Physiol; 1997 Nov; 273(5):H2458-64. PubMed ID: 9374785
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.
Hu Y; Chen X; Pan TT; Neo KL; Lee SW; Khin ES; Moore PK; Bian JS
Pflugers Arch; 2008 Jan; 455(4):607-16. PubMed ID: 17674030
[TBL] [Abstract][Full Text] [Related]
19. A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Efficacy, time course, and role of KATP channels.
Yao Z; Gross GJ
Circulation; 1994 Mar; 89(3):1229-36. PubMed ID: 8124811
[TBL] [Abstract][Full Text] [Related]
20. KATP channels in rat heart: blockade of ischemic and acetylcholine-mediated preconditioning by glibenclamide.
Qian YZ; Levasseur JE; Yoshida K; Kukreja RC
Am J Physiol; 1996 Jul; 271(1 Pt 2):H23-8. PubMed ID: 8760153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
